FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308341346> ?p ?o ?g. }

• W4308341346 abstract "PURPOSE To describe a newly established international registry recruiting diverse patients with advanced prostate cancer across academic and community practices to address unmet needs in this population. PATIENTS AND METHODS Initiated in 2017, IRONMAN (International Registry for Men with Advanced Prostate Cancer) is a prospective cohort of patients with advanced prostate cancer. The study will enroll 5,000 patients with metastatic hormone-sensitive prostate cancer (mHSPC) or castration-resistant prostate cancer (CRPC), recruited from Australia, the Bahamas, Barbados, Brazil, Canada, Ireland, Jamaica, Kenya, Nigeria, Norway, South Africa, Spain, Sweden, Switzerland, the United Kingdom, and the United States. The study is collecting datatypes to study variation in care and treatment of advanced prostate cancer across countries and across academic, community-based, and government practices with a focus on clinical outcomes, patient-reported outcomes, epidemiologic data, biologic subtypes, and clinician questionnaires. RESULTS Through July 2022, 2,682 eligible patients were enrolled in 11 of 12 active countries. Sixty-six percent of patients have mHSPC, and 34% have CRPC. On the basis of self-report, 11% of patients are Black and 9% are Hispanic. Five Veterans Affairs Medical Centers are enrolling patients. Globally, 23% of patients report being veterans of military service. CONCLUSION To our knowledge, this is the first international cohort of people newly diagnosed with advanced prostate cancer designed to describe variations in patient management, experiences, and outcomes. IRONMAN aims to identify optimal treatment sequences to improve survival, understand patient-reported outcomes, and explore novel biomarkers to understand treatment resistance mechanisms. Insights from IRONMAN will inform and guide future clinical management of people with mHSPC and CRPC. This cohort study will provide real-world evidence to facilitate a better understanding of the survivorship of people with advanced prostate cancer." @default.
• W4308341346 created "2022-11-11" @default.
• W4308341346 creator A5000765977 @default.
• W4308341346 creator A5005231494 @default.
• W4308341346 creator A5005989132 @default.
• W4308341346 creator A5006249276 @default.
• W4308341346 creator A5013148696 @default.
• W4308341346 creator A5015634061 @default.
• W4308341346 creator A5015783535 @default.
• W4308341346 creator A5016584868 @default.
• W4308341346 creator A5020223699 @default.
• W4308341346 creator A5025596735 @default.
• W4308341346 creator A5026077284 @default.
• W4308341346 creator A5026247212 @default.
• W4308341346 creator A5032324017 @default.
• W4308341346 creator A5039415213 @default.
• W4308341346 creator A5039819959 @default.
• W4308341346 creator A5041581270 @default.
• W4308341346 creator A5049753330 @default.
• W4308341346 creator A5050185074 @default.
• W4308341346 creator A5050969352 @default.
• W4308341346 creator A5056041412 @default.
• W4308341346 creator A5056766924 @default.
• W4308341346 creator A5060792750 @default.
• W4308341346 creator A5061721402 @default.
• W4308341346 creator A5064732405 @default.
• W4308341346 creator A5072116005 @default.
• W4308341346 creator A5072409740 @default.
• W4308341346 creator A5076880587 @default.
• W4308341346 creator A5077071889 @default.
• W4308341346 creator A5089561857 @default.
• W4308341346 date "2022-11-01" @default.
• W4308341346 modified "2023-10-17" @default.
• W4308341346 title "IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer" @default.
• W4308341346 cites W1569100977 @default.
• W4308341346 cites W1996053420 @default.
• W4308341346 cites W2048505725 @default.
• W4308341346 cites W2064468246 @default.
• W4308341346 cites W2070301254 @default.
• W4308341346 cites W2103959341 @default.
• W4308341346 cites W2118997750 @default.
• W4308341346 cites W2127571714 @default.
• W4308341346 cites W2137467802 @default.
• W4308341346 cites W2139110501 @default.
• W4308341346 cites W2141454098 @default.
• W4308341346 cites W2142904655 @default.
• W4308341346 cites W2163224056 @default.
• W4308341346 cites W2165246410 @default.
• W4308341346 cites W2171012735 @default.
• W4308341346 cites W2278392405 @default.
• W4308341346 cites W2779098860 @default.
• W4308341346 cites W2785690270 @default.
• W4308341346 cites W2792086148 @default.
• W4308341346 cites W2912991678 @default.
• W4308341346 cites W2936872510 @default.
• W4308341346 cites W2944891078 @default.
• W4308341346 cites W2951071083 @default.
• W4308341346 cites W2977469640 @default.
• W4308341346 cites W3031020438 @default.
• W4308341346 cites W3032046986 @default.
• W4308341346 cites W3033281579 @default.
• W4308341346 cites W3033684926 @default.
• W4308341346 cites W3049351332 @default.
• W4308341346 cites W3084238852 @default.
• W4308341346 cites W3087416729 @default.
• W4308341346 cites W3128646645 @default.
• W4308341346 cites W3143127604 @default.
• W4308341346 doi "https://doi.org/10.1200/go.22.00154" @default.
• W4308341346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36332173" @default.
• W4308341346 hasPublicationYear "2022" @default.
• W4308341346 type Work @default.
• W4308341346 citedByCount "2" @default.
• W4308341346 countsByYear W43083413462023 @default.
• W4308341346 crossrefType "journal-article" @default.
• W4308341346 hasAuthorship W4308341346A5000765977 @default.
• W4308341346 hasAuthorship W4308341346A5005231494 @default.
• W4308341346 hasAuthorship W4308341346A5005989132 @default.
• W4308341346 hasAuthorship W4308341346A5006249276 @default.
• W4308341346 hasAuthorship W4308341346A5013148696 @default.
• W4308341346 hasAuthorship W4308341346A5015634061 @default.
• W4308341346 hasAuthorship W4308341346A5015783535 @default.
• W4308341346 hasAuthorship W4308341346A5016584868 @default.
• W4308341346 hasAuthorship W4308341346A5020223699 @default.
• W4308341346 hasAuthorship W4308341346A5025596735 @default.
• W4308341346 hasAuthorship W4308341346A5026077284 @default.
• W4308341346 hasAuthorship W4308341346A5026247212 @default.
• W4308341346 hasAuthorship W4308341346A5032324017 @default.
• W4308341346 hasAuthorship W4308341346A5039415213 @default.
• W4308341346 hasAuthorship W4308341346A5039819959 @default.
• W4308341346 hasAuthorship W4308341346A5041581270 @default.
• W4308341346 hasAuthorship W4308341346A5049753330 @default.
• W4308341346 hasAuthorship W4308341346A5050185074 @default.
• W4308341346 hasAuthorship W4308341346A5050969352 @default.
• W4308341346 hasAuthorship W4308341346A5056041412 @default.
• W4308341346 hasAuthorship W4308341346A5056766924 @default.
• W4308341346 hasAuthorship W4308341346A5060792750 @default.
• W4308341346 hasAuthorship W4308341346A5061721402 @default.
• W4308341346 hasAuthorship W4308341346A5064732405 @default.
• W4308341346 hasAuthorship W4308341346A5072116005 @default.
• W4308341346 hasAuthorship W4308341346A5072409740 @default.

• next